Solgenics Limited Confirmation of Change in Website Address (3029S)
March 08 2023 - 4:45AM
UK Regulatory
TIDMSGN
RNS Number : 3029S
Solgenics Limited
08 March 2023
News Release
Confirmation of Change in Website Address
8 March 2023: Solgenics Limited ( the "Company") announces that,
further to its announcement on 2 March 2023, regarding the change
of its name from Ncondezi Energy Limited to Solgenics Limited, the
Company's website address has changed to www.solgenics.com with
immediate effect. The information required to be disclosed pursuant
to AIM Rule 26 of the AIM Rules for Companies can be accessed on
https://www.solgenics.com/aim-rule-26/ .
In addition the Twitter handle has been updated to
@solgenicsafrica
E nqu iries
For further information please visit www.solgenics.com or
contact:
Solgenics: Hanno Pengilly +27 (0) 71 362 3566
Liberum Capital Limited: Scott Mathieson, Edward Thomas, +44 (0) 20 3100
NOMAD & Joint Broker Kane Collings 2000
Novum Securities
Limited +44 (0) 20 7399
Joint Broker Colin Rowbury 9427
Pimlico Advisory
Ltd +44 (0) 777 56 55
Investor Relations Elizabeth Johnson 927
About Solgenics
Solgenics (formerly Ncondezi Energy) is an African renewable
energy development company focused on the development of a 300MW
solar PV plus BESS renewable energy in the Tete Province in
northern Mozambique (the "Tete Solar Project").
It is the intention that the Tete Solar Project will connect to
the Mozambique grid with target power off takers
in Mozambique and the Southern African Power Pool ("SAPP").
The Tete Solar Project takes full advantage of Mozambique's
leading sustainable energy resources and is fully
aligned with Government's objective to become a champion for
energy transition impacting all Southern Africa.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCUPUMWWUPWUBR
(END) Dow Jones Newswires
March 08, 2023 04:45 ET (09:45 GMT)
Solgenics (LSE:SGN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Solgenics (LSE:SGN)
Historical Stock Chart
From Aug 2023 to Aug 2024